Overall and progression-free survival of patients with metastatic colorectal cancer: A real-world prospective, longitudinal cohort study on the continuum of care (PROMETCO)

被引：0
|
作者：
Koopman, M. [1 ]
Garcia-Carbonero, R. [2 ]
Pinto, C. [3 ]
Mitroshkin, A. [4 ]
Bodoky, G. [5 ]
Mineur, L. [6 ]
Bourgeois, V. [7 ]
Mare, M. [8 ]
Ruiz-Casado, A. [9 ]
Fernandez Montes, A. [10 ]
O'Connor, J. M. R. [11 ]
Sullivan, A. [12 ]
Choucair, E. [13 ]
Sicaire, M. [13 ]
Marti, F. E. [14 ]
Bachet, J-B. [15 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands
[2] Dept Med Oncol, Hosp Univ Doce Octubre Imas12, UCM, Madrid, Spain
[3] Clin Canc Ctr Azienda USL, Med Oncol, Reggio Emilia, Italy
[4] Univ Tubingen, Akad Lehrkrankenhaus, Klinikum Freudenstadt, Freudenstadt, Germany
[5] Szent Laszlo Hosp, Dept Oncol, Budapest, Hungary
[6] Inst Canc St Catherine Avignon Provence, GI & Liver Oncol Unit, Avignon, France
[7] Ctr Hosp Boulogne, Oncol Digest, Boulogne Sur Mer, France
[8] Mediterranean Inst Oncol, Med Oncol Unit, Catania, Italy
[9] Univ Hosp Puerta Hierro, Med Oncol, Madrid, Spain
[10] Complexo Hosp Univ Ourense, Dept Med Oncol, Orense, Spain
[11] Inst Alexander Fleming, Dept Clin Oncol, Buenos Aires, DF, Argentina
[12] Servier, Servier Med Affairs, Boston, MA USA
[13] Servier, Servier Med Affairs, Suresnes, France
[14] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[15] Sorbonne Univ, Serv Hepatogastroenterol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1795
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
604P
引用
收藏
页码：S434 / S435
页数：2
相关论文
共 50 条
  • [41] Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database
    Courtinard, Coralie
    Gourgou, Sophie
    Jacot, William
    Carton, Matthieu
    Guerin, Olivier
    Vacher, Laure
    Bertaut, Aurelie
    Le Deley, Marie-Cecile
    Perol, David
    Marino, Patricia
    Levy, Christelle
    Uwer, Lionel
    Perrocheau, Genevieve
    Schiappa, Renaud
    Bachelot, Florence
    Parent, Damien
    Breton, Mathias
    Petit, Thierry
    Filleron, Thomas
    Loeb, Agnes
    Pelissier, Simone Mathoulin
    Robain, Mathieu
    Delaloge, Suzette
    Bellera, Carine
    BMC MEDICINE, 2023, 21 (01)
  • [42] PREDICTIVE MARKERS FOR OVERALL AND PROGRESSION-FREE SURVIVAL WITH CAPOX IN SECOND-LINE CHEMOTHERAPY OF METASTATIC COLORECTAL CANCER
    Solis Hernandez, M. D. P.
    Jimenez Fonseca, P.
    Perez, Q.
    Alvarez Fernandez, C.
    Ruiz, L.
    Rodriguez Rubi, D.
    Li, W.
    Sanchez, M. L.
    Faez, L.
    Vieitez, J. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 218 - 218
  • [43] Continuing bevacizumab with second-line chemotherapy for metastatic colorectal cancer prolongs overall and progression-free survival
    Williamson, Ruth
    IMMUNOTHERAPY, 2012, 4 (08) : 757 - 758
  • [44] Circadian robustness as an independent predictor of prolonged progression-free survival (PFS) and overall survival (OS) in 436 patients with metastatic colorectal cancer (mCRC).
    Levi, Francis
    Parganiha, Arti
    Karaboue, Abdoulaye
    Innominato, Pasquale F.
    Giacchetti, Sylvie
    Garufi, Carlo
    Dispersyn, Garance
    Focan, C. N. J.
    Iacobelli, Stefano
    Bjarnason, Georg A.
    Moreau, Thierry
    Dugue, Pierre Antoine
    Waterhouse, Jim
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [45] Evaluating the relationship between progression-free survival (PFS) and overall survival (OS) in clinical trials of patients (pts) with metastatic colorectal cancer (mCRC)
    Sidhu, R.
    Rong, A.
    Dahlberg, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Oxaliplatin improves progression-free survival in patients with colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (01): : 83 - 83
  • [47] Cetuximab significantly improves progression-free survival and disease control in metastatic colorectal cancer patients
    不详
    ONCOLOGY-NEW YORK, 2007, 21 (06): : 739 - 739
  • [48] Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non-Small Cell Lung Cancer Trials Using Real-World Data
    Ton, Thanh G. N.
    Pal, Navdeep
    Trinh, Huong
    Mahrus, Sami
    Bretscher, Michael T.
    Machado, Robson J. M.
    Sadetsky, Natalia
    Chaudhary, Nayan
    Lu, Michael W.
    Riely, Gregory J.
    CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2844 - 2853
  • [49] Predicting real-world effectiveness using overall survival and progression-free survival-based clinical trial efficacy measures
    Shafrin, Jason
    Hou, Ningqi
    Brookmeyer, Ron
    Peneva, Desi
    Vine, Seanna
    Park, Jinhee
    Zhang, Jie
    Figlin, Robert A.
    Lakdawalla, Darius N.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
    Hogdall, Estrid
    Fung, Eric T.
    Christensen, Ib Jarle
    Yip, Christine
    Nedergaard, Lotte
    Engelholm, Svend Aage
    Risum, Signe
    Petri, Anette Lykke
    Lundvall, Lene
    Lomas, Lee
    Hogdall, Claus
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (12) : 940 - 952
12345